Institution: Masonic Cancer Center, University of Minnesota
Research: Develop strategies to enhance the anti-tumor activity of endogenous Natural Killer (NK) cells in patients with solid tumor malignancies; and develop “off the shelf” reagents to activate NK cells, overcome inhibitory receptor signaling, and target them to specific tumor antigens.
